uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted February 02, 2021

FDA Warns Seller of Ginger, Echinacea, and More

On December 10, 2020, the FDA issued a warning letter to Prairie Dawn Herbs following a review of the company's website, which found statements made about the company's products Chest Tea, Ginger Oil, Dandelion root Tincture, Echinacea purpurea Tincture, Antispasmodic Tincture, Ginger Tincture, and Cayenne Tincture to be drug claims.

For example, Ginger Oil and Ginger Tincture were promoted with statements such as "Ginger has strong antibacterial properties and is effective against food borne pathogens of Shigella, E coli and Salmonella" and "useful for treating colds and flu, as well as upper respiratory infections."

See ConsumerLab's Ginger Supplements, Chews & Spices Review for tests of related products.

Echinacea purpurea Tincture was promoted with statements such as "Echinacea... has antibacterial properties" and "A dropperful of tincture can be squirted at the back of the throat and held there for relief of strep throat."

See ConsumerLab's Echinacea Supplements Review for tests of related products.

In addition, the products were found to be misbranded because they do not contain adequate directions for safe use, as required by federal regulations.

Prairie Dawn Herbs was warned in October, 2020 for selling herbal products with unsupported claims that they can treat COVID-19.

For more information, use the link below.

Warning Letter: Prairie Dawn Herbs

See related warnings:

Seller of Omega-3 Warned for Making Claims to Treat Focus, Mood

Seller of Cholesterol, Weight Loss Products, and More Warned for Claims

FDA Warns Seller of Evening Primrose Oil and Beta Glucan

FDA Warns Seller of Curcumin and Cholesterol Supplements

FDA Warns Immusist for Drug Claims